Skip to main content Skip to navigation
Washington State University

Allen I. White

Dr. Allen I. White served on the pharmacy faculty for 39 years and was dean of the College of Pharmacy and Pharmaceutical Sciences from 1960 to 1979.

The Allen I. White Lectureship

This lectureship was established on Feb. 12, 1979, by Professors Charles Martin and Vishnu Batia as a tribute to Dean Allen White. The two professors wanted to do something to honor Dr. White upon his retirement in 1979. Dr. White did not want a banquet or a scholarship, and suggested the lectureship. The purpose of the lecture is to discuss the scientific, social or political aspects of pharmacy or related matters. The first lecture was held April 29, 1981. Speakers are chosen to reflect Dr. White’s professional philosophy: effective leadership does not simply accept change, but views it as an ongoing professional challenge to be grasped and shaped to meet the needs of society.

Upcoming Lecture

2022: April 11, Robert G. Gish, MD, adjunct professor at the University of Nevada School of Medicine, adjunct professor at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, clinical professor at Loma Linda University, medical director of the Asia Pacific Health Foundation and of the Hepatitis B Foundation, staff physician at a Federal Clinic, Board Member of the Vietnam Viral Hepatitis Alliance (VVHA), will present, “Metabolic Associated Fatty Liver Disease (MAFLD)– Search for a Treatment.”

Past Lectures

2020: March 5, Leslie Z. Benet, PhD, Professor and former Chairman (1978-1998) of Bioengineering and Therapeutic Sciences, University of California San Francisco, “Protein Binding, Transporters, IVIVE and PBPK Modeling”

2019: April 3, Bill J. Smith, PhD, Executive Director at Gilead Sciences and Head of the Drug Metabolism and Pharmacokinetics Department, “Long Acting Therapeutics – Pharmacologic, Physicochemical, and Nonclinical Pharmacokinetic Characterization of a Novel HIV Capsid Inhibitor”

2018: March 13, Dr. Richard Okita, Program Director in the Division of Pharmacology, Physiology and Biological Chemistry of the National Institute of General Medical Sciences, “Navigating Your Life in the Biomedical Sciences: One Person’s Perspective”

2017: March 2, Dr. Julie Johnson, Dean, University of Florida College of Pharmacy, “Advancing Patient Care through Pharmacogenomics.”

2016: March 2, Paul B. Watkins, MD, Director of the University of North Carolina Institute for Drug Safety Sciences; Professor of Medicine, Pharmacy and Public Health at the University of North Carolina, Chapel Hill, “Why good drugs are sometimes bad for the liver.”

2015: February 27, Nahum Sonenberg, FRS, James McGill Professor, Department of Biochemistry and the Rosalind and Morris Goodman Cancer Research Centre, McGill University, “Translational control of cancer and autism.”

2014: October 15, Katherine R. Tuttle, MD, FASN, FACP, Executive Director for Research, Providence Health Care; Professor of Basic Medical Sciences, Washington State University; Clinical Professor of Medicine, Division of Nephrology, University of Washington School of Medicine, “From Hopes and Dreams to Reality: Novel Therapies for Diabetic Kidney Disease.”

2012: December 7, Dr. John Collier, Department of Microbiology and Immunology, Harvard Medical School, Boston. “Anthrax Toxin: Structure, Action, and Applications.”

2012: April 13, Dr. Irl Hirsch, Professor of Medicine at the University of Washington, “The Rationale of FLAT-SUGAR.”

2010: April 16, Dr. John D. Scott, University of Washington Department of Pharmacology, “Cell Signaling in Space and Time.”

2009: April 15, Dr. Oliver W. Press, Director of Clinical Research for Hematology at Fred Hutchinson Cancer Research Center in Seattle, will talk about ‘Immunotherapy of Malignant Lymphomas.”

2008: April 8, Tuesday, Dr. Robert D. Gibson, Professor Emeritus of Biopharmaceutical Sciences, School of Pharmacy, University of California, San Francisco,“Life, Liberty and the Pursuit of Dignity.”

2007: April 3, Dr. John DiGiovanni, Chair of the Department of Carcinogenesis and Director of the Center for Research on Environmental Disease, M.D. Anderson Cancer Center at the University of Texas, “Identification of New Targets and Mechanisms in Cancer Prevention.”

2004: Oct. 18, Susan C. Winckler, R. Ph., Esq., Vice President for Policy and Communications and Staff Counsel for the American Pharmacist Association, “The Medicare Drug Benefit: Threat or Opportunity or… Both?”

2002: Oct. 18, Dr. Sidney Wolfe, co-founder and Director of the D.C.-based Public Citizen Health Research Group, “Problems with the Health Care System and the Pharmaceutical Industry.”

2001: April 4, Dr. Carolyn L. Westhoff, Associate Professor of Clinical Obstetrics and Gynecology and Public Health at the College of Physicians and Surgeons, Columbia University, and Medical Director of Family Planning at Columbia Presbyterian Medical Center in New York City, “Mifepristone (RU 486) – Science, Medicine and Politics.”

2000: March 31, Dr. Henri Manasse Jr., Executive Vice President and CEO of the American Society of Health System Pharmacists, “To Err is Human: Creative, Fail-Safe Medication Systems.”

1999: April 6, Dr. Jerry B. Hook, Chairman and CEO of Sparta Pharmaceuticals in Horsham, Pa., “The Use of Biotechnology in the Search for New Treatments of Stroke and Other Reperfusion Injuries.”

1995: Sept. 18, Dr. Linda Strand, Associate Professor of Pharmacy Practice at the University of Minnesota, and Co-Director of the Institute of Pharmacy Care, “Pharmaceutical Care: Turning Theory into Practice.”

1994: March 30-April 2, Dr. Jeffrey Blumberg, Associate Director of the USDA Human Nutrition Research Center on Aging at Tufts University, “Vitamins and Disease Prevention.”

1993: April 4-6, Melburn Whitmire, President and CEO of Whitmire Distribution Corp., “Reforming Our Ailing Health Care System.”

1990: September, Dr. Lawrence Weaver, Dean Emeritus of the College of Pharmacy at the University of Minnesota, “Why Not?”

1989: Oct. 10, Dr. Jerry B. Hook, Vice President of Development Research and the development department, SmithKline Beecham Pharmaceuticals, “Impact of Biotechnology on Drug Discovery and Development.”

1988: September, Dr. Arnold R. Martin, Professor of Medicinal Chemistry at the College of Pharmacy at the University of Arizona, “Design of Selective Serotonin Receptor Agonists and Antagonists.”

1985: Oct. 9, Dr. Gerhard Levy, Distinguished Professor of Pharmaceutics at the State University of New York at Buffalo, “Kinetics of Drug Action in Disease State.”

1984: Oct. 3, Dr. Robert Langridge, Professor of Pharmaceutical Chemistry and Director of the computer graphics laboratory in the School of Pharmacy at the University of California at San Francisco, “Molecular Graphics: From Star Trek II to the Proceedings of the National Academy.”

1984: April 25, Dr. Thomas M. Ludden, Associate Professor of Pharmacy at the College of Pharmacy at the University of Texas and Associate Professor of Pharmacy in the Department of Pharmacology at the University of Texas Health Sciences Center at San Antonio, “Individualization of Drug Dosage.”

1983: No lecture this year

1982: Oct. 27, Takeru Higuchi, chairman of the Department of Pharmaceutical Chemistry at the University of Kansas, “Recent Developments in Drug Dosage Forms.”

1981: April 29, Dr. Leslie Z. Benet, Chair of the Department of Pharmacy at the University of California at San Francisco, “The Quick Pill Game: Science or Seance in Drug Advertising.”